Profile data is unavailable for this security.
About the company
Greenfern Industries Limited is a New Zealand-based medicinal cannabis and biotechnology company. The Company operates primarily from their medicinal cannabis research facility and hemp processing hub in Normanby, South Taranaki. The Company cultivates premium and consistent cannabis and through research and development, creates a pharmaceutical grade product range. The Company operates through two segments: Cannabis and therapeutics products, and Electricity generation. The Cannabis and therapeutics products segment reflects the activities of the arrangement with Cannvalate to manufacture and distribute white label products. The Electricity generation segment includes the generation and distribution of electricity. The Company operates through two geographical segments: New Zealand and Australia.
- Revenue in NZD (TTM)274.76k
- Net income in NZD-1.76m
- Incorporated2018
- Employees--
- LocationGreenfern Industries Ltd127 Normanby Road,, NormanbyAUCKLAND 4671New ZealandNZL
- Websitehttps://gfi.nz
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortin Laboratories Ltd | 667.71k | -799.66k | 2.74m | -- | -- | -- | -- | 4.10 | -5.02 | -5.02 | 4.10 | -- | -- | -- | -- | -- | -- | 0.376 | -- | 1.01 | -30.46 | 22.23 | -119.76 | 0.3017 | -- | -6.87 | -- | -- | -26.86 | -40.48 | 76.53 | -- | -- | -- |
Saroja Pharma Industries India Ltd | -1.95bn | -1.95bn | 3.22m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -9.78 | -- | -6.97 | -- | -- | -- |
Greenfern Industries Ltd | 274.76k | -1.76m | 3.91m | -- | -- | 1.40 | -- | 14.23 | -0.0175 | -0.0175 | 0.0027 | 0.0243 | 0.0796 | -- | 8.39 | -- | -50.94 | -- | -66.40 | -- | 130.93 | -- | -639.93 | -- | 0.7376 | -5.26 | 0.162 | -- | 239.65 | -- | -0.4622 | -- | -- | -- |
Hydration Pharmaceuticals Co Ltd | 16.40m | -13.23m | 4.29m | -- | -- | -- | -- | 0.2618 | -0.0627 | -0.0627 | 0.0776 | -0.002 | 1.18 | 1.61 | 6.60 | -- | -94.86 | -79.98 | -143.75 | -111.57 | 53.70 | 48.73 | -80.69 | -99.53 | 1.37 | -21.48 | 1.10 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
Bod Science Ltd | 3.60m | -8.61m | 4.61m | -- | -- | -- | -- | 1.28 | -0.0557 | -0.0557 | 0.0235 | -0.0046 | 0.7533 | 2.42 | 8.05 | -- | -180.40 | -94.62 | -465.66 | -145.77 | 69.23 | 47.08 | -239.47 | -129.48 | 0.8319 | -- | 3.71 | -- | -34.70 | 23.20 | -47.10 | -- | 8.23 | -- |
Cambium Bio Ltd | -30.56k | -396.37k | 4.98m | -- | -- | -- | -- | -- | -0.0012 | -0.0012 | -0.00009 | -0.0036 | -0.039 | -- | -- | -- | -50.58 | -49.44 | -- | -292.47 | -- | -- | -- | -118.34 | -- | -- | -- | -- | -- | -- | 60.86 | -- | -- | -- |